؉ T cells. In this work we studied the down-regulation of the virus-specific CD8
Viruses use a number of strategies, including escape from immune recognition or induction of immunosuppression, to avoid immunological surveillance and thereby persist in the host (reviewed in references 1, 14, 35, 45, and 59) . The immune response to viruses involves activation of both effector arms of the adaptive immune system, i.e., virus-specific CD8 ϩ T cells and neutralizing antibody production, as well as components of the innate response, including type I (alpha/beta interferon [IFN-␣/␤]) and type II (IFN-␥) IFNs (27, 56, 69, 72) . IFNs are an essential part of both the innate and adaptive cytokine responses to viral infection, having important functions in the regulation of the immune system (12, 24, 38, 49) . In addition to inducing an antiviral state (24, 38) , IFNs are noted for their function in many immunoregulatory processes, including upregulation of major histocompatibility complex (MHC) class I and II molecules, activation of macrophages and natural killer cells (68) , augmentation of dendritic cell responses, and promotion of proliferation and survival of activated lymphocytes (15, 36, 60) .
Infection of mice with the relatively noncytopathic lymphocytic choriomeningitis virus (LCMV) results in an early and dramatic elevation of IFN-␣/␤, within day 2 to 3 of infection (18, 67) . The adaptive T-cell immune response, characterized by profound CD8
ϩ -T-cell expansion and IFN-␥ production, is elicited by day 7 to 9 after infection (11, 23, 73) . The central concept derived from studies with this viral system is that in previously unexposed individuals a race occurs between the development of cell-mediated immunity and the extent of viral replication. Virus clearance or persistence is determined by a critical balance between the virus-specific immune response and the rate of virus replication. Consistent with this model, virus control and functional T-cell memory, or viral persistence and exhaustion of virus-specific CD8 ϩ T cells, reflect the ends of the spectrum of the virus-host interaction. Thus, infection with invasive strains of LCMV that can rapidly replicate and produce a high viral load can drive the activation and vigorous expansion of antigen-specific CD8 ϩ T cells, followed by their functional inactivation resulting in irreversible anergy and/or deletion (43, 71) . This phenomenon, called clonal exhaustion, results in viral persistence. In contrast, infection with less invasive, slowly replicating LCMV strains induces virus-specific T cells capable of efficiently clearing the infection. Typically, a fraction of these cells persist as long-term memory cells after virus elimination. These distinct outcomes of LCMV infection are critically controlled by host factors, which determine the magnitude of the virus-specific cytotoxic-T-lymphocyte (CTL) response, and by the rapidity of spread of the virus, determined by the virus strain and the route and dose of infection (2, 40, 42) . Thus, susceptibility to persistent infection by clonal exhaustion correlates with a quantitatively lower virus-specific CTL response from the host and with rapidly replicating LCMV strains.
We previously observed that the ability of individual virus strains to induce extensive spread of infection correlates with their relative resistance to IFN-␣/␤ and IFN-␥ (39); hence, fast-growing IFN-resistant isolates, such as Docile and CL 13 Armstrong, readily induce persistent infection, whereas slowgrowing IFN-sensitive strains, such as WE, Aggressive, and Armstrong, do not. Thus, it is of interest to further understand the roles played by IFNs during the establishment of persistent infections, and LCMV serves as a valuable model for such studies. It is particularly important to determine the impact of IFNs on viral dissemination during the onset of infection and to elucidate their role in initiation and regulation of the T-cell response and therefore the outcome of infection. Clonal expansion and differentiation of LCMV-specific CD8 ϩ T cells reportedly proceed normally in the absence of IFN-␥, and the importance of this cytokine during acute LCMV infection is influenced by the invasiveness of the virus strains used (34, 39, 48, 58) . However, complete inhibition of virus clearance following treatment with antibody specific to IFN-␥ has been reported (61, 70) . This correlated with a greatly reduced CTL response and suggested an essential role for IFN-␥ in generation of virus-specific CD8 ϩ T cells. Similarly, studies with mice deficient in the IFN-␣/␤ pathway revealed that LCMV-WE is able to initiate a persistent infection due to the absence of virus-specific CD8 ϩ T cells, while clearance of LCMV-Armstrong proceeds but with slower kinetics (19, 46, 63) . Together, these studies imply an essential role for IFN-␣/␤ or IFN-␥ in LCMV infection, which can determine the outcome of acute infection. However, the mechanisms by which IFNs are operational in this respect (direct suppression of virus replication and/or regulation of adaptive antiviral responses) are not well understood.
In this work the kinetics of virus replication and the development of the virus-specific CTL response were studied in mice deficient in receptors for IFN-␣/␤, IFN-␥, or both IFN-␣/␤ and IFN-␥ during infection with LCMV strains with different potentials for causing persistent infection. The specific CD8 ϩ -CTL response was examined by direct visualization with MHC class I tetramers complexed to LCMV epitopes and with stimulation of IFN-␥ expression by viral peptides. The results reveal a critical role for both IFN-␣/␤ and IFN-␥ in restricting LCMV spread at the onset of infection and thus preventing extinction of the antiviral T-cell response. Our study shows that production of IFN-␣/␤ and/or IFN-␥ critically regulates the virus-host balance during the acute phase of infection, such that a high viral burden drives responding cells into different programs of exhaustion. This dampening of virus-specific CD8
ϩ -T-cell responses in the early phase of infection results in a protracted or permanent persistence of infection.
MATERIALS AND METHODS

Mice. Mice deficient in IFN-␣/␤ receptor (IFN-␣/␤R
Ϫ/Ϫ ), IFN-␥ receptor (IFN-␥R Ϫ/Ϫ ), or both IFN-␣/␤ and IFN-␥ receptors (IFN-␣/␤-␥R Ϫ/Ϫ ) on the 129/SvEv background (29, 46, 63) , originally obtained from B&K Universal Limited (Hull, United Kingdom), were bred and maintained under specificpathogen-free conditions. Age-matched 129/SvEv control mice were purchased from Jackson Laboratories (Bar Harbor, Maine). All mice used in this study had the H-2 b MHC, and animals were kept and experiments were performed in accordance with institutional animal welfare guidelines.
Viruses. LCMV-WE was originally obtained from F. Lehmann-Grube (Hamburg, Germany), and LCMV-Docile and LCMV-Aggressive (variants isolated from an LCMV-WE [UBC] carrier mouse) were obtained from C. J. Pfau (Troy, N.Y.) as plaque-purified second passage virus (52) . LCMV-Armstrong and CL 13 Armstrong viruses were obtained originally from M. B. A. Oldstone (Scripps Clinic and Research Foundation, La Jolla, Calif.) (20) and Rafi Ahmed (Emory University Vaccine Center, Atlanta, Ga.) (2) . CL 13 Armstrong is a variant isolated from the spleen cells of an adult BALB/WEHI mouse neonatally infected with LCMV-Armstrong.
Virus titers and neutralization assay. LCMV titers in the spleen and neutralizing antibody titers in serum were determined with an immunological focus assay (8) . Neutralizing titers were defined as the dilution of serum causing half-maximal reduction of plaques of LCMV with the same amount of virus inoculated with control serum and measured as Ϫlog 2 , starting with a 1:10 dilution of serum.
Depletion of CD8 ؉ -or CD4 ؉ -T-cell subsets in vivo. Mice were depleted of CD8 ϩ -or CD4 ϩ -T-cell subsets by intraperitoneal injection of purified specific antibody (YTS169 anti-CD8 or YTS191 anti-CD4) as previously described (41) . Antibody was administrated 1 day before and 2 days after infection as indicated. This treatment depleted Ͼ99% of the splenic CD4
ϩ -T-cell population for a 3-to 4-week period, but within 2 months these mice had reconstituted their T-cell subsets and contained normal levels of CD4 ϩ T cells. However, although these mice recovered their T-cell populations, virus-specific CD4
ϩ -T-cell activity was not detectable in the periphery (due to persisting virus antigen in the thymus resulting in negative selection), as determined by measuring virus-specific antibody activity by enzyme-linked immunosorbent assay (ELISA) and plaque neutralization assay (10, 44) . Alternatively, CD4
ϩ T cells were eliminated on day 20 after infection by treatment with anti-CD4 antibody on day 20, on day 23, and continuing at monthly intervals throughout the experiment. Similarly, mice treated with antibody to CD8 depleted Ͼ90% of their CD8 ϩ T cells, and while the CD8
ϩ -T-cell population eventually returned to normal levels, functional virus-specific CD8 ϩ T cells were undetectable. Viral peptides. Peptides were synthesized at the Medical College of Georgia Molecular Biology Core Facility (Augusta, Ga.), using a Perkin-Elmer Applied Biosystems (Berkeley, Calif.) 433A peptide synthesizer. The LCMV-specific CTL epitope peptides used in this study were the H-2D b -binding peptides GP1 [33] [34] [35] [36] [37] [38] [39] [40] [41] (KAVYNFATC), GP2 276-286 (SGVENPGGYCL), NP [396] [397] [398] [399] [400] [401] [402] [403] [404] (FQPQNGQFI), and GP1 92-101 (CSANNSHHYI) and the H-2K b -binding peptides GP1 [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] (AVYNFATCGI) and NP 205-212 (YTVKYPNL). Except for LCMV-Docile, which contains an amino acid change in the peptide GP2 [276] [277] [278] [279] [280] [281] [282] [283] [284] [285] [286] (380 N3S ), all virus strains used in this study were conserved in epitopes recognized by virus-specific T cells. Note that the mutation (380 N3S ) in LCMV-Docile substantially reduces the ability of the GP2 276-286 peptide to bind H-2D b . CTL response. CTL precursor activity was determined in a bulk culture system as described previously (45) . Briefly, splenocytes were prepared from LCMVinfected mice at the indicated time points. Cells were cultured for 5 days at densities of 4 ϫ 10 6 , 2 ϫ 10 6 , and 0.5 ϫ 10 6 cells/well together with peptidepulsed (0.1 g/ml) irradiated (30 Gy) splenocytes (4 ϫ 10 6 cells/well) or virusinfected peritoneal macrophages (5 ϫ 10 5 cells/well) in 2 ml of Iscove's modified Dulbecco's medium supplemented with 10% fetal calf serum and 10 U of recombinant murine interleukin-2 (IL-2) per ml. Restimulated cells were resuspended in 1 ml of medium per culture well, and serial threefold dilutions of effector cells were tested in a 51 Cr release assay using MC57G (H-2 b ) cells infected with virus or pulsed with 10 g of the indicated peptide per ml as target cells.
Quantitative analysis of virus-specific CD8 ؉ T cells in spleen. MHC-peptide tetramers for staining of epitope-specific T cells were prepared as previously described (3, 4, 21, 47) . Soluble MHC class I (H-2D b ) with a specific biotinylation site and human ␤2-microglobulin were produced in large amounts as recombinant proteins by transforming Escherichia coli strain BL21(DE3) with the plasmid pET23-D b -BSP, pET23-K b -BSP, or pHN1-␤2m (kindly provided by J. D. Altman, Emory University, Atlanta, Ga.). Expression of the proteins was induced with isopropyl-␤-thiogalactopyranoside as described previously (4) . Folding, purification, and biotinylation of H2-D b peptide complexes were performed as described previously (3) . Finally, biotinylated MHC-peptide complexes were tetramerized by addition of phycoerythrin-conjugated streptavidin (Molecular Probes, Eugene, Oreg. [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] or NP [205] [206] [207] [208] [209] [210] [211] [212] . After 6 h of culture, cells were harvested, washed once in FACS buffer, and surface stained with phycoerythrin-conjugated monoclonal rat antibody specific to mouse CD8␣ (clone 53-6-72) . After washing, cells were stained for intracellular IFN-␥ using a Cytofix/Cytoperm kit (Pharmingen) according to the manufacturer's instructions. Fluorescein isothiocyanate-conjugated monoclonal rat antibody specific to murine IFN-␥ (clone XMG1.2) and its isotype control antibody (rat immunoglobulin G1 [IgG1]) were used to identify cytokine-positive cells. Stained cells were washed a further time and fixed in PBS containing 0.1% paraformaldehyde. Samples were analyzed as described above. PFU of LCMV-WE demonstrated that viral burdens peaked at around day 3 to 6 at levels of 7 log 10 PFU/g of spleen and were below the limit of detection by day 12 (Fig. 1) . Virus clearance also proceeded efficiently in mice infected with 10 6 PFU of LCMV-WE, although viral titers peaked earlier (day 2) and declined by day 15 (data not shown). Similarly, 129/SvEv mice infected with 10 2 PFU of the Docile strain of LCMV cleared virus by day 15, but viral titers increased more rapidly and peaked at slightly higher levels (7.5 log 10 PFU/g of spleen) compared to infection with 10 2 PFU of LCMV-WE ( Fig. 1B  and C) . In contrast, 129/SvEv mice infected with a relatively high dose (10 6 PFU) of Docile initially failed to clear the virus and retained high virus levels in many tissues (spleen, thymus, and kidney) for several weeks (Fig. 1A and data not shown) . Interestingly, virus levels declined over time to below the detection limit by day 50 after infection.
RESULTS
Contributions
Extended studies of IFN-␣/␤R Ϫ/Ϫ , IFN-␥R Ϫ/Ϫ , or IFN-␣/␤-␥R Ϫ/Ϫ mice infected with LCMV-WE (10 2 PFU) or LCMVDocile (10 2 or 10 6 PFU) revealed strikingly different outcomes for the viral infection compared to that in control (129/SvEv) mice with intact IFN responses (Fig. 1) . Thus, kinetic studies of virus replication revealed that the absence of IFN-␣/␤ responsiveness significantly increased sensitivity to LCMV infection, as determined by higher peak viral titers (up to 2 log units) at day 3 or 5 compared to the controls. This was most clearly seen for infection with 10 2 PFU of strain Docile or WE ( Fig. 1B 
and C). As a consequence of this, IFN-␣/␤R
Ϫ/Ϫ mice failed to clear infection with LCMV-Docile and these mice became virus carriers, retaining high levels of virus in several organs (Ͼ100 days). Infection with LCMV-WE resulted in time-limited persistence of virus infection, and virus levels declined over time to below the detection limit by day 80. Similarly, the absence of IFN-␥ responsiveness also increased sensitivity to LCMV infection, such that IFN-␥R Ϫ/Ϫ mice failed to control infection with 10 6 PFU of LCMV-Docile ( Fig. 1 ). However, peak viral titers were not significantly different in IFN-␥R Ϫ/Ϫ mice compared to the control (129/SvEv) population, which is consistent with our earlier observation of LCMV-Docile resistance to IFN-␥ effects. In agreement with earlier reports (48) , infection of IFN-␥R Ϫ/Ϫ mice with 10 2 PFU of LCMV-Docile or -WE induced a severe fatal wasting disease, and the mice succumbed to infection by day 9 to 14 ( Fig. 1) . Inactivation of both IFN-␣/␤ and IFN-␥ responses drastically increased susceptibility to virus infection, resulting in persistence of the virus at high levels in IFN-␣/␤-␥R Ϫ/Ϫ mice infected with either LCMV-WE or -Docile (Fig. 1) . Thus, major contributions to virus replication and hence the course and outcome of LCMV infection are determined by both IFN-␣/␤-and IFN-␥-mediated antiviral mechanisms. Hence, susceptibility of LCMV strains to the antiviral effects of IFNs, IFN-␣/␤ in particular, is a critical factor for the restriction of virus spread in vivo and thus protection from virus persistence.
Contribution of IFN-␣/␤ and IFN-␥ to control of acute infection with the CL 13 Armstrong or Armstrong strain of LCMV. Next, to assess whether the significant contribution of the IFN response towards viral clearance noted for Docile and WE infection can be generalized to other LCMV strains, kinetic studies of virus clearance were carried out with LCMV strain Armstrong and its variant CL 13 Armstrong. As expected, virus clearance proceeded efficiently in 129/SvEv mice infected with LCMV-Armstrong. Thus, studies of infection with 10 2 PFU (not shown) or 10 5 PFU of Armstrong demonstrated an acute infection with viral burdens below the limit of detection by day 10 or 15 after infection, respectively ( Fig. 2 and data not shown). Consistent with the experiments shown in Fig. 1, 10 2 PFU of CL 13 Armstrong was efficiently eliminated from the spleen by day 15; however, a relatively high dose of 10 6 PFU persisted for several weeks. Interestingly, virus burdens declined over time and were below limits of detection by day 70 after infection.
The absence of IFN-␣/␤ responsiveness significantly increased sensitivity to infection with Armstrong (10 5 PFU) or CL 13 Armstrong (10 2 or 10 6 PFU). Relative to 129/SvEv control mice, IFN-␣/␤R Ϫ/Ϫ mice showed accelerated kinetics of virus replication and higher peak viral titers, conditions which favor protraction of infection for an extended period varying between 2 and 8 weeks (Fig. 2) . In the absence of IFN-␥ responsiveness, long-term persistence of virus infection was observed only in mice infected with 10 6 PFU of CL 13 Armstrong (except for one mouse of seven that cleared the infection at day 90). Note that these mice were not free of disease signs, and we have, albeit infrequently, observed mortality in our experiments. In contrast, 10 2 PFU of CL 13 Armstrong was cleared efficiently, and no sign of disease development was observed. Likewise, clearance of infection with 10 2 PFU of Armstrong was achieved within 7 to 10 days (data not shown), while mice infected with 10 5 PFU developed a lethal wasting disease and died by days 9 to 14 after infection (Fig. 2) . Finally, elimination of both IFN-␣/␤ and IFN-␥ pathways renders mice susceptible to infection with either virus strain, and permanent virus persistence was observed irrespective of the dose of infection (Fig. 2 ). Taken together with the kinetic studies of virus clearance, this shows that the absence of either IFN-␣/␤ or IFN-␥ pathways increases sensitivity to LCMV infection, as observed by a delay in or abolition of virus clearance compared to that in animals with intact IFN responsiveness. The development of wasting syndrome and the subsequent death of mice in the absence of IFN-␥ responsiveness are dependent on the conditions of infection. Thus, under conditions where either an initial high viral load caused persistent infection or initial low viral burdens were cleared rapidly by the host immune system, mice developed few symptoms of disease and recovered from infection. In contrast, where an imbalance between virus replication and the host immune system occurred, animals succumbed to a fatal wasting disease, which has previously been recognized to be mediated by virusspecific T cells (28, 48) .
IFN-␣/␤-and IFN-␥-mediated regulation of the virus-specific CD8
؉ -CTL response during infection of mice with the WE or Docile strain of LCMV. As host CD8 ϩ T cells are critical for efficient clearance of LCMV infection and their inactivation (via deletion and/or anergy) during the acute phase of infection results in persistence of infection, the development of the virus-specific CD8 Fig. 3A and B) . Interestingly, the numbers of NP 396-404 peptide-specific CD8 ϩ T cells declined over time and were below detectable levels by day 30. In striking contrast, GP1 33-41 -specific CD8 ϩ T cells persisted at high levels over a 3-month observation period (Ͼ100 days). Both tetramer-binding T-cell populations in these mice exhibited antiviral functions initially (day 6), producing IFN-␥ after stimulation with the appropriate peptide, but rapidly became unresponsive by day 9 after infection. However, even when the infection had been controlled (around day 50), GP1 33-41 -specific T cells did not rapidly regain their capacity to elicit antiviral functions. Infection of 129/SvEv with 10 2 PFU of LCMVDocile resulted in a vigorous expansion of GP1 [33] [34] [35] [36] [37] [38] [39] [40] [41] and NP 396-404 CD8 ϩ T cells that cleared the infection within 2 weeks and persisted at high frequencies, retaining a functional phenotype ( Fig. 3C and D) . Likewise, studies on mice infected with LCMV-WE (10 2 PFU), including the profile of the GP2 276-286 epitope-specific CD8 ϩ -T-cell response, yielded comparable results (Fig. 3E to G) .
Infection of IFN-␣/␤R Ϫ/Ϫ mice with LCMV-Docile (10 2 or 10 6 PFU), causing permanent persistence of infection, revealed another interesting phenotype (Fig. 3 A to D) . In these mice GP1 33-41 -specific CD8 ϩ T cells became completely unre- Data are means and standard errors of the means for three to five mice. The limit of detection was 10 3 antigen-specific cells per spleen. These analyses were performed to correlate the kinetics of virus replication ( Fig. 1) with the kinetics of virus-specific CD8
ϩ -T-cell responses (panels A, B, and C in Fig. 1 correspond to panels A and B, C and D, and E to G here, respectively).
sponsive (based on IFN-␥ production) by day 15 after infection and persisted at high levels, retaining the nonfunctional phenotype over a 3-month period; however, their levels declined to below detectable levels between days 80 and 100 after infection. NP 396-404 -specific CD8 ϩ T cells were eliminated by day 40 after infection. Extended studies with IFN-␣/␤R Ϫ/Ϫ mice with a protracted course of LCMV-WE infection (10 2 PFU) revealed a phenotype different from that seen in 129/SvEv mice ( Fig. 3E to G) . Thus, GP1 33-41 -or GP2 276-286 -specific CD8 ϩ T cells are functional during the initial phase of infection and subsequently persist at high levels. However, the fraction of epitope-specific CD8 ϩ T cells showing a functional deficit increased progressively until no functional T cells were detectable between days 50 and 60. However, this unresponsiveness was transient, with IFN-␥ production on restimulation resuming at around day 70. In contrast, NP 396-404 -specific
CD8
ϩ T cells were functionally unresponsive by day 12 and were subsequently physically deleted by day 50 after infection.
Studies with IFN-␥R Ϫ/Ϫ mice infected with LCMV-Docile (10 6 PFU) revealed that GP1 33-41 -specific CD8 ϩ T cells persist for at least 80 days, having lost antiviral function at around day 30 after infection, whereas NP 396-404 -specific cells were deleted by day 30 (Fig. 3A and B) . IFN-␥R Ϫ/Ϫ mice infected with a low dose (10 2 PFU) of LCMV-Docile ( Fig. 3C and D) or -WE (Fig. 3E to G) died within 2 weeks after infection but developed a rigorous virus-specific CD8 hypothesis that an imbalance between virus spread and the host immune response results in the immune-mediated pathology that is instrumental in death of the animal. Finally, the virus-specific CD8 ϩ -T-cell response in IFN-␣/␤-␥R Ϫ/Ϫ mice infected with LCMV-Docile (10 6 or 10 2 PFU) was comparable that seen in IFN-␣/␤R Ϫ/Ϫ mice under similar conditions of infection, although functional unresponsiveness proceeded over a more extended period in these mice. Similarly, infection of IFN-␣/␤-␥R Ϫ/Ϫ mice with LCMV-WE (10 2 PFU) resulted in a drastic expansion of GP1 33-41 -specific CD8 ϩ T cells, which persisted as long as day 100 after infection, having lost the capacity to elicit antiviral function around day 15, but NP 396-404 -or GP2 276-286 -specific cells were deleted by day 30 or 50, respectively ( Fig. 3E to G) . Combined, the tetramer binding and IFN-␥ staining results indicate that acute infection is characterized by expansion and maintenance of functional T cells, whereas persistent infection is characterized by expansion and loss of T-cell function with eventual physical deletion.
IFN-␣/␤-and IFN-␥-mediated regulation of virus-specific CD8
؉ T cells during infection of mice with the Armstrong or CL 13 Armstrong strain of LCMV. To further correlate the link between susceptibility of the host to chronic infection and the extent of virus-specific CD8
ϩ -T-cell exhaustion, the kinetics of the LCMV-specific T-cell response were observed in Armstrong-and CL 13 Armstrong-infected mice deficient in IFN pathways. As evident from Fig. 4A to C, data obtained from 129/SvEv mice infected with CL 13 Armstrong (10 6 PFU) revealed an interesting new pattern for virus-specific CD8
ϩ -T-cell regulation. Thus, GP1 [33] [34] [35] [36] [37] [38] [39] [40] [41] or GP2 276-286 peptide-specific CD8 ϩ T cells were elicited efficiently during the acute phase of infection and persisted at high levels in the host. These cells exhibited a fully functional phenotype in the initial phase of infection and progressively lost function (around 99%) by day 15, but later (by day 70), after virus clearance was completed, they regained a fully functional phenotype. NP 396-404 CD8 ϩ T cells were rapidly deleted within the first 2 weeks after infection This finding demonstrated that a threshold of functional virus-specific CD8
ϩ -T-cell activity must be maintained for resolution of a chronic infection. During the course of acute infection of 129/SvEv mice with a relatively low dose of either CL 13 Armstrong (10 2 PFU) or Armstrong (10 5 PFU), virus-specific CD8 ϩ T cells directed against the major epitopes expanded to high frequencies and exhibited antiviral effector functions (Fig.  4D to I) .
Next, we evaluated the fate of virus-specific CD8 ϩ T cells in IFN-␣/␤R Ϫ/Ϫ mice. Similar patterns of T-cell regulation were obtained during protracted infection with CL 13 Armstrong (10 6 or 10 2 PFU). Thus, GP1 [33] [34] [35] [36] [37] [38] [39] [40] [41] or GP2 276-286 virus-specific CD8 ϩ T cells persisted in a nonresponsive state for as long as 100 days (beyond the time of virus clearance by around day 70). Deletion of NP 396-404 CD8 ϩ T cells proceeded rapidly within 15 to 30 days after infection (Fig. 4A to F) . Infection of IFN-␣/␤R Ϫ/Ϫ mice with Armstrong (10 5 PFU) elicited a vigorous response, with high levels of GP1 33-41 -and GP2 276-286 -specific CD8 ϩ T cells (Fig. 4G to I ). In these mice a fraction (around 10%) of these cells remained functional, and the LCMV infection was resolved by day 30 ϩ T cells at high levels but rapidly deleted NP 396-404 -specific cells (Fig. 4A to C) . In contrast, IFN-␥R Ϫ/Ϫ mice infected with 10 2 PFU of CL 13 Armstrong, which is cleared by day 15, developed high levels of tetramer-positive CD8 ϩ T cells which retained functionality and persisted for at least 90 days (Fig. 4D to F) . Finally, IFN-␥R Ϫ/Ϫ mice injected with 10 5 PFU of Armstrong, which causes a lethal wasting disease in these mice, developed a T-cell response against the GP1 33-41 , GP2 276-286 , and NP 396-404 epitopes prior to death (Fig. 4G to  I ). However, while the percentages of D b -peptide tetramerpositive CD8 ϩ T cells remained relatively high (up to 20%), the overall T-cell responsiveness of these mice was lower than that in the 129/SvEv controls due to a profound loss of splenocytes associated with the wasting syndrome.
Finally, analyses of the immune response in IFN-␣/␤-␥R Ϫ/Ϫ mice infected with CL 13 Armstrong (10 6 PFU) revealed that activated CD8 ϩ T cells were generated against all three epitopes examined in almost equal numbers (Fig. 4A to C) . However, GP1 33-41 -specific cells became progressively unresponsive by day 50 to 70 (some 20 to 40 days later than in IFN-␣/␤R Ϫ/Ϫ mice) and were eventually deleted by day 90. Similarly, GP2 276-286 -or NP 396-404 -specific cells were deleted after a brief initial period of expansion. This pattern was repeated in IFN-␣/␤-␥R Ϫ/Ϫ mice infected with 10 2 PFU of CL 13 Armstrong or 10 5 PFU of Armstrong, with the exception that GP1 33-41 -specific cells were not deleted once they had become nonresponsive (Fig. 4D to I) .
Taken together, these results provide additional evidence for the inverse correlation between antigenic load and responsiveness of virus-specific CD8 ϩ T cells. The degree of T-cell activation, which probably determines the ratio of functional to nonfunctional antigen-specific T cells in the transition phase between acute and persistent infection, dictates whether the infection is resolved or not. In addition, the results are consistent with the concept that the relative contribution of mechanisms operating to silence antigen-specific T-cell responses (anergy or deletion) can vary depending upon the epitope specificity of cells. Thus, NP 396-406 tetramer-binding CD8 ϩ T cells are more sensitive to deletion than GP2 276-286 -specific cells, whereas GP1 33-41 -specific T cells are relatively resistant and are deleted only under conditions of long-term virus persistence. CD8
؉ -T-cell effector functions are lost in mice with a protracted persistent infection. The results described above revealed a close association between virus persistence and exhaustion (anergy and/or deletion) of the virus-specific CD8 ϩ -T-cell repertoire. However, under certain conditions of infection (e.g., 129/SvEv mice infected with 10 6 PFU of LCMV-Docile), permanent persistence of infection was not observed and the virus was eventually cleared from the host. This occurred despite the absence of functional CD8 ϩ T cells specific to dominant epitopes, as determined by intracellular IFN-␥ staining of restimulated MHC-tetramer-binding cells. It is possible in this case that resolution of infection may be mediated by an altered physiological pattern of T-cell response, such as synthesis of alternate cytokines, which would not be detected in these experiments. In addition, the tetramer-MHC-peptide complex and IFN-␥ secretion staining assay techniques are limited by their ability to resolve a signal over background staining by FACS (around 0.1% of CD8 ϩ T cells). Thus, it is possible that functional CD8 ϩ T cells specific to dominant or even subdominant epitopes, which escape Tcell exhaustion at the onset of infection and persist at low levels, are capable of subsequently mounting an effective antiviral response and go on to clear the viral infection.
To address these possibilities, intracellular staining was performed on splenocytes from 129/SvEv mice infected with LCMV-Docile (10 6 PFU). No IFN-␥-secreting CD8 ϩ T cells specific to subdominant epitopes (GP1 92-101 and NP 205-212 ) were detectable, and as previously reported (71), the cells did not exhibit altered patterns of cytokine production. Thus, tumor necrosis factor alpha, IL-2, IL-4, or IL-10 was not detectable by intracellular cytokine staining after peptide stimulation in vitro (data not shown). Next, as an independent test of functional activity, we measured the ability of splenocytes from these mice to develop cytotoxic activity towards the virus or individual peptide epitopes following stimulation in vitro. This analysis was extended to include IFN-␣/␤R Ϫ/Ϫ , IFN-␥R [205] [206] [207] [208] [209] [210] [211] [212] [data not shown]) epitopes were detectable in mice with protracted infection during the initial phase but not in the later phase. Consistent with the IFN-␥ staining data, splenocytes from 129/SvEv mice infected with CL 13 Armstrong (10 6 PFU) initially exhibited substantial cytotoxic activity, almost lost their cytotoxic activity by day 15, but later (by day 30) regained a fully functional phenotype (data not shown). To further address the functional behavior of virus-specific T cells, parallel studies were conducted on mice infected with 10 2 PFU of Docile or CL 13 Armstrong. As evident from Table 2 , the magnitude of CTL activity obtained following in vitro restimulation with virus-infected macrophages as antigen-presenting cells correlates with the IFN-␥ staining data. Thus, cytotoxic activity was detected in the initial phase of infection in both virus-mouse combinations but was later lost in mice with chronic infection, while cytotoxic activity was sustained at high levels in animals that eliminate the virus in the acute phase. Taken together, the above findings indicate that during chronic infection, virus-specific CD8 ϩ T cells become incapable of eliciting their normal array of effector functions, including cytotoxicity and cytokine production. This is true for all situations of chronic infection except 129/SvEv mice infected with a Splenocytes isolated on days 6, 9, 15, and 30 after infection were stimulated in vitro with GP1 [33] [34] [35] [36] [37] [38] [39] [40] [41] or NP 396-404 peptide-pulsed splenocytes as described in Materials and Methods. The cytolytic activity of restimulated splenocytes cultured at a density of 4 ϫ 10 6 cells/well was measured in a 51 Cr release assay, using MC57G cells pulsed with 10 g of GP1 [33] [34] [35] [36] [37] [38] [39] [40] [41] NP 396-404 peptide per ml. Restimulated splenocytes were resuspended in 1 ml of medium per culture well, and serial threefold dilutions of effector cells were performed. Lysis of untreated target cells was Յ5% at the highest effector cell/target cell ratio. Results are representative of those from three separate experiments.
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T-CELL EXHAUSTION DURING PERSISTENT VIRAL INFECTION 8417 CL 13 Armstrong (10 6 PFU), where no complete extinction of antiviral function (cytotoxicity or IFN-␥ production) was observed.
Contribution of CD4 ؉ T cells and neutralizing antibodies in clearance of a protracted infection in the absence of functional virus-specific CD8
؉ T cells. CD8 ϩ T cells are critical for clearance of LCMV infection, and their depletion results in persistence of virus infection. However, under certain conditions, as described above, virus was eventually cleared from mice with protracted infection, although functional CD8 ϩ T cells were undetectable. Evidence for CD4 ϩ T cells and neutralizing antibody contributing to the resolution of LCMV infection has been obtained in several experimental settings and may provide an explanation for the eventual clearance of virus following a protracted infection. Note that CD4
ϩ -T-cell help is essential for virus-specific antibody (IgM or IgG) production and for maintaining specific CD8
ϩ -T-cell responses (41) . To test this hypothesis, neutralizing antibody titers were measured in the four strains of mice during chronic infection with Docile or CL 13 Armstrong (10 6 PFU). The data presented in Table 3 suggest a correlation between the neutralizing antibody titer and resolution of the infection. Thus, higher levels of antibody activity observed in 129/SvEv mice were associated with eventual clearance, by day 70 of the infection, with LCMV-Docile, while the lower neutralization titers in IFN-␣/␤R Ϫ/Ϫ , IFN-␥R Ϫ/Ϫ , or IFN-␣/␤-␥R Ϫ/Ϫ mice were insufficient for controlling chronic infection. Similar results were obtained for infection with 10 6 PFU of CL 13 Armstrong (data not shown). Next, the contribution of CD4 ϩ T cells and the antibody response in clearance of the chronic infection was tested by depletion of CD4 ϩ T cells from 129/SvEv mice infected with 10 6 PFU of LCMV-Docile. As evident from Fig. 5 , virus was not cleared when mice were treated with antibody against CD4 at the time of infection. This protracted infection was associated with poor antiviral antibody response (Ͼ99% reduction of antibody levels detected by ELISA compared to untreated controls and no detectable neutralizing antibody activity) (data not shown). In contrast, depletion of CD4 ϩ T cells on day 20 after infection, when virus-specific CD8 ϩ T cells became unresponsive, did not inhibit antibody production, and sera contained antiviral antibody activity equal to or greater than that from controls as detected by ELISA or plaque neutralization assay. Virus titers declined with kinetics similar to those for non-antibody-treated controls, falling below the threshold of detection by day 50 and remaining undetectable for a period of around 2 months. However, at the end of this period (day 100), virus in the spleen reemerged and replicated to high titers. In addition, CD4 ϩ -T-cell depletion at the time of infection did not significantly affect expansion of virus-specific CD8 ϩ T cells that exhibited a fully functional phenotype in the initial phase of infection, but these CD8 ϩ T cells progressively lost function and persisted at slightly (two-to fivefold) lower levels compared to controls for several weeks before rapidly declining to below detectable levels at between days 80 and 100 Docile  CL 13  Docile  CL 13  Docile  CL 13  Docile  CL 13   6  1  43  43  49  58  47  52  18  31  3  2 4  2 6  1 8  3 6  3 0  3 0  9  1 3  9  8  10  2  12  14  12  3  7  9  1  70  70  14  28  70  65  44  55  3  48  49  6  15  50  41  23  30  9  2 8  2 
a Splenocytes isolated on days 6, 9, and 20 after infection were stimulated in vitro with virus-infected macrophages as described in Materials and Methods. The cytolytic activity of restimulated splenocytes cultured at a density of 4 ϫ 10 6 cells/well was measured in a 51 Cr release assay, using virus-infected MC57G target cells. Restimulated splenocytes were resuspended in 1 ml of medium per culture well, and serial threefold dilutions of effector cells were performed. Lysis of untreated target cells was Յ5% at the highest effector cell/target cell ratio. Results are representative of those from three separate experiments.
b ND, not determined. after infection. Similarly, mice depleted of CD4 ϩ T cells on day 20 after infection exhibited only a moderate reduction (two-to fivefold) in levels of functionally inactive GP1 33-41 -specific CD8 ϩ T cells that persisted for 2 to 3 weeks before their levels progressively declined. This occurred despite virus clearance by day 50 with kinetics comparable to those for infected untreated controls. Depletion of CD8 ϩ T cells on day 20 after infection had no effect on virus clearance, with virus falling to undetectable levels by day 50 associated with high levels of LCMV-specific antibody (data not shown). In conclusion, these data support an important role for CD4 ϩ T cells and antibody-producing B cells in resolution of long-term LCMV infection, especially in situations where CD8 ϩ -T-cell activity is lost during the initial phase of infection.
DISCUSSION
In this work, we studied the down-regulation of the virusspecific CD8
ϩ -T-cell response (clonal exhaustion) during per- ϩ T cells initially exhibiting antiviral function lose this function and persist in this state for several weeks. However, after virus levels decline below threshold levels, functional CD8 ϩ T cells become detectable again. The origin of these cells is unknown, but they may be anergic virus-specific T cells, which have regained their function in the antigen-free environment, or newly selected virus-specific T cells emerging from the antigen-free thymus. (iii) During permanent persistence of infection, activated antigen-specific cells progressively lose their function and either persist indefinitely in this state or are deleted in the late stages of infection. A further distinction in the last two scenarios is that anergy followed by physical deletion of virusspecific CD8 ϩ T cells can operate to silence certain epitopespecific CD8
ϩ T cells irrespective of whether permanent or time-limited persistence of virus infection is observed. Thus, NP 396-406 tetramer-binding CD8 ϩ T cells are more sensitive to deletion than GP2 276-286 -specific cells, whereas GP1 33-41 -specific T cells are relatively resistant and are deleted only under conditions of long-term virus persistence. Finally, the data concur with and provide further experimental evidence for the concept that an appropriate balance between cellular and humoral components of the immune system to avoid host disease caused by immunopathology and prevent immune escape variations of the pathogen is a feature of a successful immune response with definitive viral clearance. Thus, failure of CD8 ϩ T cells to rapidly clear the virus due to their functional exhaustion may lead to a protracted viral persistence. In this situation, CD4 ϩ helper T cells and neutralizing antibody produced by B cells can become the principal arm of antiviral defense, and viral clearance can be achieved at a later stage of infection. Long-term persistence of infection can occur if the effectiveness of both arms of the immune response is lost or drastically reduced. Furthermore, an imbalance between viral spread and the host immune response can lead to host death, due to excessive activation of CD8 ϩ T cells resulting in lethal immune pathology. This has been observed in our experiments with IFN-␥R Ϫ/Ϫ mice under conditions of infection where rapid viral clearance or viral persistence cannot be readily achieved.
A vital question concerns the mechanisms and factors that determine the nature and kinetic patterns of functional inactivation and/or physical deletion of virus-specific CD8 ϩ T cells during persistent infection. Down-regulation of the virus-specific CD8 ϩ -T-cell response is the first critical step for survival and persistence of the virus in the host, but CD4 ϩ helper T cells are also susceptible to anergy or physical deletion as reported previously (51, 65) . According to these earlier reports, antigen-specific CD4 ϩ T cells persist for several weeks and retain a functional phenotype in C57BL/6 mice infected with a high dose of LCMV-Docile, which causes permanent viral persistence, but they progressively become unresponsive, and eventually a fraction are physically deleted. Furthermore, the process of exhaustion proceeds with much slower kinetics, in that anergic CD4 ϩ T cells become detectable at around day 70, compared to virus-specific CD8 ϩ T cells, which develop an anergic phenotype by day 15. As CD4 ϩ helper T cells are central regulators for the B-cell response, exhaustion of virusspecific CD4
ϩ T cells at this late time may affect the production of neutralizing antibody, which represents a critical component of the host immune system for control of persistent LCMV infection (6, 17, 53, 57) . The concept that acute or persistent viral infection (protracted or permanent) is dictated by the degree and kinetics of down-regulation of the virusspecific immune response can explain the different outcomes of the viral infection in this study. As virus-specific CD8 ϩ T cells in mice with LCMV persistence become functionally inactive or deleted in the early stages of infection, the eventual clearance of infection seen in mice with protracted viral persistence may involve intervention of antigen-specific CD4 ϩ T cells and antibody production. Three roles for virus-specific CD4 ϩ T cells can be considered. Either (i) virus-specific CD4 ϩ T cells are critically involved in induction and differentiation of CD8 ϩ T cells, for example, by secretion of cytokines (such as IL-2) or increasing expression of costimulatory molecules (e.g., B7-1 and B7-2) on antigen-presenting cells (32) , (ii) CD4 ϩ T cells are involved in the virus clearance process by regulating neutralizing antibody production, or (iii) they function by direct inhibition of virus replication via secretion of antiviral factors (e.g., IFN-␥ or tumor necrosis factor alpha) (6, 25, 26, 53, 57) . A major role for CD4 ϩ T cells in the induction and differentiation of CD8 ϩ T cells can be excluded, as our data indicate that depletion of CD4 ϩ T cells at the time of infection has no significant effect on the kinetics of proliferation or functional inactivation of virus-specific CD8 ϩ T cells during the acute phase of infection. However, it remains possible that CD4 ϩ T cells do have a function in the maintenance of CD8 ϩ -T-cell activation and influence the longevity of the CD8 ϩ -Tcell population once it has become anergic. Our data most favor a role for CD4 ϩ T cells in initiation of the virus-specific antibody response responsible for eventual clearance of LCMV infection, as elimination of CD4 ϩ T cells inhibits antiviral antibody production. The fact that CD4
ϩ -T-cell depletion on day 20 after infection, when functional virus-specific CD8 ϩ T cells are not detectable, does not prevent clearance of virus infection and can no longer affect virus-specific antibody production provides further support for an antibody-mediated role in the clearance of a protracted viral persistence. Note that the induction and differentiation of virus-specific B cells are advanced on day 20 after infection and may no longer be dependent on CD4
ϩ -T-cell help. Consistent with this, we have reproducibly observed moderate levels of neutralizing antibody in IFN-deficient mice infected with a high dose of LCMV-Docile, while 129/SvEv control mice exhibited significantly higher antibody levels, having cleared the infection. However, we should keep in mind that the virus-specific antibody response is auxiliary in the virus clearance process and that inactivation of CD8 ϩ T cells is the crucial step for virus persistence. This view is consistent with studies by us and others (9, 16, 37, 66) showing that CD4 ϩ T cells are critical only in threshold situations where complete exhaustion of CD8 ϩ T cells normally does not occur and thus virus resolution proceeds with delayed kinetics. Finally, a vital question concerns the mechanisms allowing virus to reemerge in the spleens of infected mice that were depleted of CD4 ϩ T cells by day 20 after infection. One plausible explanation for this could be that neutralizing antibody escape variants are selected at late times in the course of infection as a result of immune pressure and are able to persist in the host. Analyses to test this hypothesis are under way.
It is well recognized that the interaction between T cells and antigen-presenting cells can result in T-cell activation, anergy, or deletion, depending on the level of T-cell receptor (TCR) engagement (30, 33, 62) . Likewise, the levels of TCR engagement can trigger a spectrum of biological responses, such as cytotoxicity or cytokine secretion (31) . In this situation, different factors, such as the activation state of T cells, the dose of antigen, and the presence or absence of costimulation, have been shown to play a role in determining the outcome of the T-cell response. Clearly, the complexity of the molecular interactions between virus-infected antigen-presenting cells and T cells makes it difficult to analyze the relative contributions of these factors to the final outcome. However, the following scenarios, based on the central concept that the duration of antigen stimulation determines the fate of T cells during persistent LCMV infection, may help to shed light on the phenomenon of T-cell exhaustion. The extent of T-cell activation can be influenced by the abundance of viral antigen presented and by the affinity of the TCR for the given MHC-peptide complex. LCMV-specific CD8 ϩ T cells recognize the dominant epitope peptide (GP1 [33] [34] [35] [36] [37] [38] [39] [40] [41] , GP2 276-286 , or NP 396-404 ) presented by H-2D b molecules on virus-infected cells. One possible scenario is that the density of the peptide-MHC complexes on infected cells in persistently infected mice differs for individual epitopes. Consequently, CD8 ϩ T cells specific for individual peptides may not be similarly activated, and therefore the fate of these cells could be differentially regulated. Evidence against this is provided in a recent report, where estimation of peptide density on LCMV-infected MC57G cells revealed that GP1 [33] [34] [35] [36] [37] [38] [39] [40] [41] was present at Ϸ1,000 copies/cell, NP 396-404 was present at 160 copies/cell, and GP2 276-286 was present at 90 copies/cell (22) . Note that NP 396-406 -specific CD8 ϩ T cells are more sensitive to deletion than GP2 276-286 -specific cells, whereas GP1 33-41 -specific T cells are relatively resistant to deletion in chronically infected mice. However, the fact that differential regulation of viral gene expression may occur in different cell types or that different amounts of the viral glycoprotein and nucleoprotein are produced in different stages of the viral replication cycle leaves this possibility open. Consistent with this, it has been found that nucleoprotein accumulated in large amounts in different cell types in persistently infected mice (50) . Alternatively, the range of T-cell responses may result from differences in TCR affinity and dissociation rates of epitope-specific T cells. In this case, even if viral peptides are presented in similar densities on infected cells, the responding T cells may undergo different activation programs and consequently succumb to different fates (anergy versus physical deletion). It is possible that sustained signaling from high levels of antigen in the absence of appropriate costimulation could explain the functionally inactive phenotype of T cells. Alternatively, it has been suggested that clonal exhaustion is a consequence of a targeted infection of professional antigen-presenting cells (dendritic cells), rendering these critical accessory cells targets for destruction by an antiviral immune response (13, 55) . The facts that induction of virus-specific T cells (CD8 ϩ and CD4 ϩ ) proceeds normally and that some of these cells persist for many weeks while others are deleted might argue more for a TCR-specific regulated process rather than a deficit in stimulation of T cells by accessory cells. However, infection of dendritic cells in chronically infected mice may disrupt the production of cytokines critical for survival and activation of virus-specific T cells. This is an attractive possibility that will be addressed in detail in ongoing studies. The concepts developed above to explain the different patterns of virus infection in this study rely solely on the function of IFNs in regulating virus-specific T-cell responses through modulation of viral replication and spread. However, IFNs have been proposed to regulate T-cell homeostasis (expansion, immunodominance, hierarchies, death phase, and memory phase of T cells) through pathways independent of their antiviral function (27) . Our data are largely consistent with the view that the principal function of IFNs in LCMV infection is via direct control of virus spread; however, there are observations that may be better interpreted in the context of direct regulation of T-cell responses by IFNs. Thus, development of the wasting disease and subsequent death of IFN-␥R Ϫ/Ϫ mice infected with 10 2 PFU of LCMV-Docile in this study, or with LCMV-Traub in studies by others (48) , suggest that IFN-␥ deficiency can result in impaired silencing of virus-specific CD8 ϩ -T-cell responses and thus exacerbation of immune-mediated pathology. More-detailed analyses are required to determine the mechanisms of IFN-␥-mediated regulation of antigen-specific T-cell homeostatic under different conditions of infection with LCMV.
Resolving the issue of why the immune system ultimately fails to control some viral infections requires a comprehensive analysis of several factors and mechanisms that regulate both replication and spread of the virus and cellular and humoral host immune responses. The studies presented here clearly document that viral infections do not simply either terminate by rapid viral clearance or persist following collapse of virus control but that there are several possible outcomes lying be-tween these extreme situations, including the possibility of a balanced long-standing coexistence of virus and active T-cell immune surveillance as reported previously (7, 64) .
